Market Research Logo

Bulgaria Pharmaceuticals and Healthcare Report Q2 2016

Bulgaria Pharmaceuticals and Healthcare Report Q2 2016

BMI View: Bulgaria's healthcare sector is in need of reform to improve its efficiency; however, it is likelyto see spending cuts as the government must enforce strong cost-saving measures to reduce the budgetdeficit. Such controls to healthcare spending will produce a bleak outlook for pharmaceutical andhealthcare providers.

Headline Expenditure Projections

Pharmaceuticals: BGN2.71bn (USD1.52bn) in 2015 to BGN2.89bn (USD1.58bn) in 2016; +6.7% inlocal currency terms and +3.8% in US dollar terms. Forecast unchanged compared to the previousquarter.

Healthcare: BGN6.30bn (USD3.53bn) in 2015 to BGN6.56bn (USD3.58bn) in 2016; +4.1% in localcurrency terms and +1.3% in US dollar terms. Forecast unchanged compared to the previous quarter.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Bulgaria 2014-2020)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Bulgaria 2012-2020)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Bulgaria 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Bulgaria 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Bulgaria 2012-2020)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Bulgaria 2012-2020)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Bulgaria 2012-2020)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Bulgaria 2012-2020)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Bulgaria 2012-2020)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Bulgaria 2014-2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (Bulgaria 2014-2020)
Industry Risk/Reward Index
Central And Eastern Europe Risk/Reward Index
Bulgaria Risk/Reward Index
Rewards
Risks
Regulatory Review
Intellectual Property Issues
Pricing Regime
Reimbursement Regime
Market Overview
Healthcare Sector
Table: Healthcare Resources (Bulgaria 2010-2015)
Table: Healthcare Resources (Bulgaria 2010-2015)
Table: Healthcare Personnel (Bulgaria 2010-2015)
Table: Healthcare Activity (Bulgaria 2010-2015)
Table: NHIF Budget, 2014
Table: Bulgarian National Health Insurance Fund Revenues (BGN 000s), 2015
Research & Development
Table: Members Of ARPharM, 2014
Clinical Trials
Table: Cancer Incidence Rates, 2012-2035
Competitive Landscape
Research-Based Industry
Table: Multinational Market Activity
Generic Drugmakers
Pharmaceutical Retail Sector
Wholesale Sector
Table: Pharmaceutical Wholesale And Retail Market, 2009-2012
Company Profile
Sopharma
Demographic Forecast
Demographic Outlook
Table: Population Headline Indicators (Bulgaria 1990-2025)
Table: Key Population Ratios (Bulgaria 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Bulgaria 1990-2025)
Table: Population By Age Group (Bulgaria 1990-2025)
Table: Population By Age Group % (Bulgaria 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report